Global stomach cancer deaths decline but colorectal cancer deaths stagnate; plus, divergent results for paclitaxel/nab-paclitaxel for triple negative breast cancer

Blood & Cancer

English - October 06, 2020 08:00 - 11 minutes - 15.3 MB - ★★★★★ - 31 ratings
Medicine Health & Fitness Science Life Sciences oncologists radiotherapy cancer chemotherapy doctors healthcare hematologists hematology immunotherapy marrow Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: ESMO 2020: Late-breaking and practice-changing studies on COVID-19 and breast, lung, gastrointestinal, and other cancers

Next Episode: The psychiatry of cancer, a crossover from the Psychcast

Hematology-Oncology News:

Divergent findings with paclitaxel and nab-paclitaxel in TNBC (https://bit.ly/33vemjS) Palbociclib plus letrozole improves PFS in advanced endometrial cancer (https://bit.ly/2GIUl08) Global stomach cancer deaths decline as colorectal cancer deaths stagnate, rise (https://bit.ly/33zBVs1)

You can email the show at [email protected] and you can learn more about the show at https://www.mdedge.com/podcasts/blood-cancer